Skip to content
Research Article Open access CC BY 4.0

Dissemination of Multidrug-Resistant, Extensively Drug Resistant and Pandrug-Resistant Pseudomonas aeruginosa Isolates among In-Patients and Out-Patients in a Multi-Profile Health Care Settings

Beatrice Ngozi John-Onwe, Ugonna Cassandra Aniokete, Francis Amadi Ibiam, Ikemesit Udeme Peter, Chidinma Stacy Iroha, Ifeanyichukwu Romanus Iroha

Journal of Advances in Microbiology · pp. 109–115 · Published 5 Oct 2023

10.9734/jamb/2023/v23i10761

Abstract

Pseudomonas aeruginosa is one of the most life-threatening pathogens, especially in healthcare settings, and a main contributor to multi-drug resistance (MDR), extensive-drug resistance (XDR), and pan-drug resistant (PDR) phenotypes. However, there is limited data on the degree of resistance of these isolates in this region. This study seeks to determine the distribution of MDR, XDR, and PDR Pseudomonas aeruginosa strains from different patient groups. A total of five hundred (500) non-duplicated strains of Pseudomonas aeruginosa of human clinical samples were collected from the Microbiology Laboratory Unit of Alex Ekwueme Teaching Hospital Abakaliki. The isolates were identified and re-characterized by standard microbiology techniques. MDR, XDR, and PDR were determined using the Kirby–Bauer disk diffusion method, and the results were analyzed using the Clinical Laboratory Standard Institute (CLSI) zone diameter breakpoints. The result shows that the overall resistant phenotype was MDR 50. 7%, XDR 20.5%, and PDR 9.6% while in samples from in-patients and out-patients, resistant phenotype proportions were MDR 43.2%, XDR 32.4%, PDR 10.1% and MDR 61.2%, XDR 29.7%, and PDR 18.5% respectively. Worrisomely, only a few tested antimicrobial agents (Amikacin, cefepime) were active against the test organism, presenting a limited therapeutic option. It is therefore imperative to establish strong regulative measures and guidelines that would help in curtailing the increasing dissemination of these superbugs in healthcare institutions in Nigeria.

Multidrug-resistant extensively drug resistant pandrug-resistant Pseudomonas aeruginosa

References (24)

  1. 1 Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial [DOI]
  2. 2 Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa [DOI]
  3. 3 An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance [DOI]
  4. 4 Influence of Multidrug Resistance and Appropriate Empirical Therapy on the 30-Day Mortality Rate of Pseudomonas aeruginosa Bacteremia [DOI]
  5. 5 Prevalence of multi-drug resistant (MDR) and extensively drug-resistant (XDR) phenotypes of Pseudomonas aeruginosa and Acinetobacter baumannii isolated in clinical samples from Northeast of Iran [DOI]
  6. 6 High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial [DOI]
  7. 7 New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review [DOI]
  8. 8 Mortality in patients with multidrug-resistant Pseudomonas aeruginosa infections: a meta-analysis [DOI]
  9. 9 Epidemiological, Microbiological, and Clinical Characteristics of Multi-Resistant Pseudomonas aeruginosa Isolates in King Fahad Medical City, Riyadh, Saudi Arabia [DOI]
  10. 10 Antibiotic combination therapy can select for broad-spectrum multidrug resistance in Pseudomonas aeruginosa [DOI]
  11. 11 New Drugs for Multidrug-Resistant Gram-Negative Organisms: Time for Stewardship [DOI]
  12. 12 Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019 [DOI]
  13. 13 Multicenter surveillance of antimicrobial susceptibilities and resistance mechanisms among Enterobacterales species and non-fermenting Gram-negative bacteria from different infection sources in Taiwan from 2016 to 2018 [DOI]
  14. 14 Resistance profile of genetically distinct clinical Pseudomonas aeruginosa isolates from public hospitals in central Pakistan [DOI]
  15. 15 Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007–16 study [DOI]
  16. 16 Virulence factors and integrons are associated with MDR and XDR phenotypes in nosocomial strains of Pseudomonas aeruginosa in a Venezuelan university hospital [DOI]
  17. 17 Efficacy of Antibiotic Combinations against Multidrug-Resistant Pseudomonas aeruginosa in Automated Time-Lapse Microscopy and Static Time-Kill Experiments [DOI]
  18. 18 In vitro activity of cefepime/zidebactam (WCK 5222) against recent Gram-negative isolates collected from high resistance settings of Greek hospitals [DOI]
  19. 19 Analysis of the Distribution and Antibiotic Resistance of Pathogens Causing Infections in Hospitals from 2017 to 2019 [DOI]
  20. 20 High mortality by nosocomial infections caused by carbapenem-resistant P. aeruginosa in a referral hospital in Brazil: facing the perfect storm [DOI]
  21. 21 Comparison of Antibiotic-Resistant Pattern of Extended Spectrum Beta-Lactamase and Carbapenem-Resistant Escherichia Coli Isolates from Clinical and Non-Clinical Sources [DOI]
  22. 22 Molecular Characterization of Carbapenemase Encoding Genes in Pseudomonas aeruginosa from Tertiary Healthcare in South Eastern Nigeria [DOI]
  23. 23 Killing Rate Kinetics of Commercially Available Brands of Ciprofloxacin and Cefotaxime on Clinical Bacterial Isolates Subjected to in vitro Antibiotic Treatments [DOI]
  24. 24 Phenotypic Characterization and Antibiogram of Non-Oral Bacteria Isolates from Patients Attending Dental Clinic at Federal College of Dental Technology and Therapy Medical Center Enugu [DOI]

Cited by 2

Prevalence of Biofilm-forming and Carbapenemase-producing Gram-negative Bacilli Colonizing Indwelling Urinary Catheters of Patients

Ikemesit Udeme Peter, Onyedikachi Chijindu Obike, Justina Nnenna Ngwu · UMYU Scientifica · 2025

Showing 1 of 2 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

31

Page views

0

PDF downloads

6

Outbound clicks

2

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.